Chandler Regional Medical Center is a full-service, acute care, not-for-profit hospital providing healthcare to the East Valley of the Phoenix Arizona metropolitan area.

There are 338 beds in Chandler Regional Medical Center.

During the past decade, Chandler Regional Medical Center conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 8 clinical trials were completed, i.e. on average, 42.1% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 4 clinical trials were completed. i.e. 44.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chandler Regional Medical Center" #1 sponsor was "Abbott Medical Devices" with 2 trials, followed by "Cardiovascular Systems Inc" with 2 trials sponsored, "Nader Sanai" with 2 trials sponsored, "St. Joseph's Hospital and Medical Center, Phoenix" with 2 trials sponsored and "Abbott Diagnostics Division" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chandler Regional Medical Center" #1 collaborator was "Barrow Neurological Institute" with 3 trials as a collaborator, "Ivy Brain Tumor Center" with 3 trials as a collaborator, "Medical University of South Carolina" with 3 trials as a collaborator, "Chandler Regional Medical Center" with 2 trials as a collaborator and "Mercy Gilbert Medical Center" with 2 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Chandler Regional Medical Center" are "Coronary Artery Disease" (3 trials), "COVID-19" (2 trials), "GBM" (2 trials), "Glioblastoma" (2 trials) and "Glioma" (2 trials). Many other conditions were trialed in "Chandler Regional Medical Center" in a lesser frequency.

Most popular intervention types in "Chandler Regional Medical Center" are "Device" (8 trials), "Drug" (8 trials), "Biological" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "AMPLATZER™ PFO Occluder" (1 trials), "ARCHITECT STAT High Sensitive Troponin I Assay" (1 trials), "ARRY-371797 (PF-07265803)" (1 trials) and "Abemaciclib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chandler Regional Medical Center" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Chandler Regional Medical Center". undefined are not yet recruiting, 7 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Chandler Regional Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Chandler Regional Medical Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".